103 related articles for article (PubMed ID: 23726002)
1. Low-dose radiation therapy (2 Gy × 2) in the treatment of orbital lymphoma.
Fasola CE; Jones JC; Huang DD; Le QT; Hoppe RT; Donaldson SS
Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):930-5. PubMed ID: 23726002
[TBL] [Abstract][Full Text] [Related]
2. Examining the utility of lower dose radiotherapy for localised primary ocular adnexal MALT lymphoma.
Leeson S; Jayamohan J; Vu H; Sundaresan P
J Med Radiat Sci; 2021 Sep; 68(3):269-273. PubMed ID: 33675287
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of partial-orbit irradiation as a treatment strategy for patients with orbital mucosa-associated lymphoid tissue lymphoma.
Chung SY; Kook KH; Oh YT
Can J Ophthalmol; 2024 Jun; 59(3):e227-e232. PubMed ID: 37084769
[TBL] [Abstract][Full Text] [Related]
4. Orbital lymphoma: role of radiation.
Yadav BS; Sharma SC
Indian J Ophthalmol; 2009; 57(2):91-7. PubMed ID: 19237780
[TBL] [Abstract][Full Text] [Related]
5. Electron therapy for orbital and periorbital lesions using customized lead eye shields.
Hayashi K; Hatsuno K; Yoshimura R; Iida T; Ayukawa F; Toda K; Taniguchi H; Shibuya H
Ophthalmologica; 2009; 223(2):96-101. PubMed ID: 19033716
[TBL] [Abstract][Full Text] [Related]
6.
Frank MJ; Reagan PM; Bartlett NL; Gordon LI; Friedberg JW; Czerwinski DK; Long SR; Hoppe RT; Janssen R; Candia AF; Coffman RL; Levy R
Cancer Discov; 2018 Oct; 8(10):1258-1269. PubMed ID: 30154192
[TBL] [Abstract][Full Text] [Related]
7. Acute and late toxicity of bilateral orbital irradiation in the management of primary intraocular lymphoma.
Milgrom SA; Cheah CY; Pinnix CC; Smith GL; Dabaja BS; Horace P; Chevez-Barrios P; Fowler NH; Gombos DS
Leuk Lymphoma; 2016 Nov; 57(11):2612-8. PubMed ID: 27075636
[TBL] [Abstract][Full Text] [Related]
8. Modelling intervention effects after cancer relapses.
González JR; Peña EA; Slate EH
Stat Med; 2005 Dec; 24(24):3959-75. PubMed ID: 16320269
[TBL] [Abstract][Full Text] [Related]
9. Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma.
Pinnix CC; Dabaja BS; Milgrom SA; Smith GL; Abou Z; Nastoupil L; Romaguera J; Turturro F; Fowler N; Fayad L; Westin J; Neelapu S; Fanale MA; Rodriguez MA; Hagemeister F; Lee HJ; Oki Y; Wang M; Samaniego F; Chi L; Esmaeli B
Head Neck; 2017 Jun; 39(6):1095-1100. PubMed ID: 28370694
[TBL] [Abstract][Full Text] [Related]
10. 4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial.
Hoskin PJ; Kirkwood AA; Popova B; Smith P; Robinson M; Gallop-Evans E; Coltart S; Illidge T; Madhavan K; Brammer C; Diez P; Jack A; Syndikus I
Lancet Oncol; 2014 Apr; 15(4):457-63. PubMed ID: 24572077
[TBL] [Abstract][Full Text] [Related]
11. Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group.
Yahalom J; Illidge T; Specht L; Hoppe RT; Li YX; Tsang R; Wirth A;
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):11-31. PubMed ID: 25863750
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of 487 patients with early-stage extra-nodal marginal zone lymphoma.
Teckie S; Qi S; Chelius M; Lovie S; Hsu M; Noy A; Portlock C; Yahalom J
Ann Oncol; 2017 May; 28(5):1064-1069. PubMed ID: 28327924
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy of indolent orbital lymphomas : Two radiation concepts.
König L; Stade R; Rieber J; Debus J; Herfarth K
Strahlenther Onkol; 2016 Jun; 192(6):414-21. PubMed ID: 27160291
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes and patterns of relapse of early-stage extranodal marginal zone lymphoma treated with radiation therapy with curative intent.
Teckie S; Qi S; Lovie S; Navarrett S; Hsu M; Noy A; Portlock C; Yahalom J
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):130-7. PubMed ID: 25863760
[TBL] [Abstract][Full Text] [Related]
15. Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group.
Illidge T; Specht L; Yahalom J; Aleman B; Berthelsen AK; Constine L; Dabaja B; Dharmarajan K; Ng A; Ricardi U; Wirth A;
Int J Radiat Oncol Biol Phys; 2014 May; 89(1):49-58. PubMed ID: 24725689
[TBL] [Abstract][Full Text] [Related]
16. Repeated courses of low-dose 2 × 2 Gy radiation therapy in patients with indolent B-cell non-Hodgkin lymphomas.
Saleh K; Michot JM; Schernberg A; Lazarovici J; Chahine C; Danu A; Khalife-Saleh N; Rossignol J; Ghez D; Martin V; Mazeron R; Fermé C; Boros A; Ribrag V; Girinsky T
Cancer Med; 2020 Jun; 9(11):3725-3732. PubMed ID: 32249547
[TBL] [Abstract][Full Text] [Related]
17. Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma.
Pinnix CC; Dabaja BS; Milgrom SA; Smith GL; Abou Yehia Z; Nastoupil L; Romaguera J; Turturro F; Fowler N; Fayad L; Westin J; Neelapu S; Fanale MA; Rodriguez MA; Hagemeister F; Lee HJ; Oki Y; Wang M; Samaniego F; Chi L; Esmaeli B
Head Neck; 2019 May; 41(5):1546. PubMed ID: 30990235
[No Abstract] [Full Text] [Related]
18. Rare Orbital Involvement Originating from Extranodal Marginal Zone Lymphoma.
Wen YC; Huang TC; Tsai WC; Lai SW
Medicina (Kaunas); 2024 Apr; 60(5):. PubMed ID: 38792889
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy of Orbital and Ocular Adnexa Lymphoma: Literature Review and University of Catania Experience.
La Rocca M; Leonardi BF; Lo Greco MC; Marano G; Finocchiaro I; Iudica A; Milazzotto R; Liardo RLE; La Monaca VA; Salamone V; Basile A; Foti PV; Palmucci S; David E; Parisi S; Pontoriero A; Pergolizzi S; Spatola C
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136328
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
